Bringing the fundamentals into focus…
Back to Cytek Biosciences, Inc.
How Cytek Biosciences, Inc. stacks up
CTKB · against 557 other Healthcare companies listed in US-listed
Profitability
24/ 100
Below the middle of the pack.
Ranked #298 of 558 · scores higher than 45% of peers
Bars: peers in each 10-point band of the profitability score82 peers with a profitability score of 20–29, including CTKB · Click a bar to see the companies
Why profitability scores 24?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets, operating margin and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 80% of peers. Return on assets: -18.0% vs peer median 1.7%
- a thinner operating margin: weaker than 79% of peers. Operating margin: -21.6% vs peer median 7.1%
- a lower return on invested capital: weaker than 76% of peers. Return on invested capital: -14.2% vs peer median 4.7%
Metric by metric
Position: dot = CTKB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CTKB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -14.2% | -7.0% | 47% | 33% | |
| Operating marginHigher is better · 479 reported | -21.6% | -2.4% | 37% | 33% | |
| Return on assetsHigher is better · 582 reported | -18.0% | -7.8% | 39% | 33% | |
| Return on equityHigher is better · 531 reported | -23.0% | -19.7% | 48% | Context only | |
| Gross marginHigher is better · 601 reported | 51.9% | 43.9% | 56% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around CTKB| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 289 | 191M USD | 25 | 38 | |
| 289 | 2.0B USD | 25 | 53 | |
| 289 | 14.0B USD | 25 | 31 | |
| 298 | 21.8B USD | 24 | 32 | |
| 298 | 775M USD | 24 | 31 | |
| 298 | 598M USD | 24 | 49 | |
| 298 | 1.5B USD | 24 | 44 | |
| 298 | 423M USD | 24 | 29 | |
| 298 | 8.8B USD | 24 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score